S 3347 New York Senate · 2023 Regular Session

Relates to the availability of buprenorphine in opioid treatment programs

Summary
Requires facilities that provide treatment for substance use disorders to have at least one practitioner qualified to administer or prescribe buprenorphine to individuals in their care with substance use disorders related to opioids.
Bill status in committee 1 of 4 stages cleared
Introduction
Jan 2023
Committee Review
Floor Vote
Governor
Introduced Jan 30, 2023 Last action Jan 3, 2024
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
3
Key actions
0
Committee
3
Jan 3, 2024
Committee
REFERRED TO ALCOHOLISM AND SUBSTANCE USE DISORDERS
upper
Feb 8, 2023
Committee
REPORTED AND COMMITTED TO FINANCE
upper
Jan 30, 2023
Committee
REFERRED TO ALCOHOLISM AND SUBSTANCE USE DISORDERS
upper
1 primary · 0 co-sponsors

Sponsors

Role
Legislator
Party
State
District
P
Photo of Nathalia Fernández
Nathalia Fernández
DDemocratic
NY
34